Clinical Trial

Clinical Study to Determine Bioequivalence Between Two Oral Medications of Empagliflozin/Metformin in 12.5 mg / 1000 mg Tablets Under Fed Conditions.

Study acronym: ACL24-PC020
Completed
View on ClinicalTrials.gov →
Summary
Prospective, longitudinal, single-dose, randomized, open-label, crossover 2x2, two treatments, two periods, two sequences controlled clinical study
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-06-03.
Trial Details
NCT Number NCT07633041
Lead Sponsor ADIUM
Conditions Bioequivalence Study in Healthy Subjects
Enrollment 42 participants
Start Date 2025-02-05
Primary Completion 2025-04-04 (estimated)
Study Completion 2025-04-04 (estimated)
Updated on ClinicalTrials.gov 2026-06-10